Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Perampanel in Korean Healthy Subjects
NCT02020486Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2013
- Primary completion
- Mar 2014
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of perampanel in epilepsy (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Pharmacokinetics of perampanel at 56 days. Started Dec 2013; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02020486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020486.